SBG

DRUG3 trials

Sponsors

Biotec Pharmacon ASA, Prince of Songkla University

Conditions

Advanced Solid TumorsDiabetesDiabetic UlcerHead and Neck CancerOral Mucositis

Phase 1

Phase I, Dose-Escalation Study of Soluble Beta-Glucan (SBG) in Patients With Advanced Solid Tumors

CompletedNCT01910597

Prince of Songkla UniversityAdvanced Solid Tumors

Start: 2013-08-01End: 2016-04-20Updated: 2021-10-11

Phase 3

Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy

CompletedNCT00790322

Biotec Pharmacon ASAHead and Neck Cancer, Oral Mucositis

Start: 2008-10-31End: 2010-02-28Updated: 2010-02-19

Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers

CompletedNCT00804414

Biotec Pharmacon ASADiabetes, Diabetic Ulcer

Start: 2008-10-31End: 2009-09-30Updated: 2010-01-26